MRSi 2023: Lucky 21 Celebrating Victories in IVF
The Stakes Are High: 7th Annual CEO Summit
|Date||Thursday, June 8, 2023|
|Time||6:00pm - 9:00pm|
Angeline N. Beltsos, MD, FACOG, TJ Farnsworth, Richard Jennings, Thomas Molinaro, MD, David Stern
Join us on Thursday, June 8th at 6pm for the CEO Summit. This is an exclusive event drawing all the high rollers, movers, & shakers together to discuss the intersection of business and medicine and what the future holds for REI's.
Angeline N. Beltsos, MD, FACOG
Angeline N. Beltsos, MD is the CEO and Clinical Medical Director of Kindbody. She is board certified in Obstetrics and Gynecology and in Reproductive Endocrinology and Infertility (REI), practicing medicine since 1991. Dr. Beltsos completed her residency in Obstetrics and Gynecology at Loyola University in 1995 followed by a fellowship in REI at Washington University in St. Louis, Missouri, completed in 1997. She has received numerous awards in teaching and has been honored as “Top Doctor” from Castle Connelly for several years. She is a popular speaker, both nationally and internationally, and a frequent media resource on the topic of infertility. Dr. Beltsos founded the Midwest Reproductive Symposium international conference in 2003, after recognizing the need for a collaborative forum for those in the reproductive field to share knowledge and best practices.
As the REI Division Education Director for the Obstetrics and Gynecology residency programs of Illinois Masonic Medical Center, Lutheran General Hospital, and St. Joseph’s Hospital Chicago, Dr. Beltsos helps educate future OB/GYN doctors. She is a Clinical Assistant Professor for the Department of Obstetrics and Gynecology at University of Illinois at Chicago.
TJ Farnsworth is the Founder and CEO of Inception Fertility™, the largest provider of comprehensive fertility clinics and services in North America. After a two-year infertility journey left Mr. Farnsworth and his wife frustrated with the process, he created Inception to put compassionate patient care at the center of fertility treatment. Inception and its family of brands expand access to different types of fertility care while leading innovations in reproductive science.
Prior to Inception Mr. Farnsworth founded SightLine Health in 2005, one of the largest providers of radiation oncology services in the U.S., with clinical operations in California, Colorado, Kansas, Texas, and Washington. In 2010, SightLine was named the fastest-growing company in Houston by the Houston Business Journal and the fourth fastest-growing healthcare company in the U.S. by Inc. Magazine.
Mr. Farnsworth sits on the board of directors of CureDuchenne, a nonprofit dedicated to finding a cure for Duchenne muscular dystrophy. Mr. Farnsworth was named one of Houston’s 40 under 40 in 2011 and was awarded the 2014 Ernst & Young Entrepreneur of the Year for Healthcare award.
Richard Jennings is CEO of US Fertility. Richard leverages his 25 years of experience as a healthcare executive to implement strategic changes and drive growth. Before joining US Fertility, Richard led multiple healthcare/life science companies through major growth and expansion. Most recently, he served as the CEO of Generate LIfe Sciences, overseeing the operations and long-term strategy of its industry-leading brands providing reproductive, stem cell, and genetic services to help grow and protect families, including California Cryobank, Donor Egg Bank, CBR, and ReadyGen. Richard holds a Bachelor of Science degree in Chemical Engineering and an MBA from Harvard Business School.
Thomas Molinaro, MD
Thomas Molinaro, MD is a Physician Partner and Director at IVI. As a board certified Reproductive Endocrinologist, Dr. Molinaro specializes in helping couples achieve their dream of becoming a family. Working with cutting edge technology such as the In Vitro Fertilization, Preimplantation Genetic Diagnosis and Comprehensive Chromosomal Screening sets his practices at Reproductive Medicine Associates of New Jersey apart. Dr. Molinaro has an intense "hands on" approach and dedicates himself to collaborating with patients to develop a treatment that is tailored to their needs and particular reproductive issues.
David Stern is CEO of Boston IVF. He has over 28 years of women’s health experience and has devoted the majority of his career to the fertility industry. He has held executive leadership positions and built successful teams while launching numerous products in pharmaceutical and biotech markets world-wide. Boston IVF is one the largest IVF centers in the United States with 10 full service IVF centers and over 30 satellite centers nationwide.
David served as CEO of Symbiomix Therapeutics a venture backed biotech company. He served on the board of California Cryobank and has held executive positions in startup companies in the women’s healthcare market, building commercial teams, developing strategy and expanding scientific partnerships for Celmatix, Ohana and OvaScience.
David was the Senior Vice President and Head of the Global Business Franchise for Fertility at Merck Serono, responsible for the strategic development and growth of the portfolio world-wide. He has an MBA with a concentration in International Marketing and Management from the F.W. Olin School of Business at Babson College and holds a Bachelors’ degree in Biology from Brandeis University.